|
|
eye morphogenesis
|
GO:0048592 |
144 |
0.805
|
|
|
|
sensory organ development
|
GO:0007423 |
393 |
0.800
|
|
|
|
regulation of cellular macromolecule biosynthetic process
|
GO:2000112 |
222 |
0.639
|
|
|
|
eye development
|
GO:0001654 |
277 |
0.623
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
200 |
0.585
|
|
|
|
specification of symmetry
|
GO:0009799 |
204 |
0.555
|
|
|
|
regulation of biological quality
|
GO:0065008 |
263 |
0.539
|
|
|
|
heart development
|
GO:0007507 |
313 |
0.538
|
|
|
|
nucleobase containing compound biosynthetic process
|
GO:0034654 |
205 |
0.509
|
|
|
|
camera type eye development
|
GO:0043010 |
222 |
0.498
|
|
|
|
rna biosynthetic process
|
GO:0032774 |
181 |
0.473
|
|
|
|
determination of left right symmetry
|
GO:0007368 |
179 |
0.471
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
78 |
0.464
|
|
|
|
determination of bilateral symmetry
|
GO:0009855 |
204 |
0.446
|
|
|
|
negative regulation of gene expression
|
GO:0010629 |
65 |
0.433
|
|
|
|
regulation of cellular metabolic process
|
GO:0031323 |
320 |
0.414
|
|
|
|
fin development
|
GO:0033333 |
77 |
0.394
|
|
|
|
embryonic organ development
|
GO:0048568 |
381 |
0.387
|
|
|
|
organic cyclic compound biosynthetic process
|
GO:1901362 |
223 |
0.377
|
|
|
|
immune system development
|
GO:0002520 |
191 |
0.369
|
|
|
|
cellular component morphogenesis
|
GO:0032989 |
336 |
0.360
|
|
|
|
columnar cuboidal epithelial cell differentiation
|
GO:0002065 |
38 |
0.358
|
|
|
|
regulation of macromolecule metabolic process
|
GO:0060255 |
317 |
0.348
|
|
|
|
heterocycle metabolic process
|
GO:0046483 |
290 |
0.346
|
|
|
|
hemopoiesis
|
GO:0030097 |
183 |
0.333
|
|
|
|
regulation of rna metabolic process
|
GO:0051252 |
224 |
0.327
|
|
|
|
retina development in camera type eye
|
GO:0060041 |
146 |
0.327
|
|
|
|
retina morphogenesis in camera type eye
|
GO:0060042 |
79 |
0.325
|
|
|
|
negative regulation of metabolic process
|
GO:0009892 |
86 |
0.323
|
|
|
|
organic substance biosynthetic process
|
GO:1901576 |
289 |
0.320
|
|
|
|
nucleic acid templated transcription
|
GO:0097659 |
181 |
0.319
|
|
|
|
neural crest cell differentiation
|
GO:0014033 |
72 |
0.312
|
|
|
|
regulation of rna biosynthetic process
|
GO:2001141 |
213 |
0.298
|
|
|
|
regulation of macromolecule biosynthetic process
|
GO:0010556 |
225 |
0.284
|
|
|
|
macromolecule biosynthetic process
|
GO:0009059 |
227 |
0.275
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
148 |
0.274
|
|
|
|
cellular macromolecule metabolic process
|
GO:0044260 |
391 |
0.268
|
|
|
|
vasculature development
|
GO:0001944 |
278 |
0.257
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
274 |
0.256
|
|
|
|
rna metabolic process
|
GO:0016070 |
219 |
0.254
|
|
|
|
regulation of nucleic acid templated transcription
|
GO:1903506 |
213 |
0.254
|
|
|
|
regulation of transcription dna templated
|
GO:0006355 |
213 |
0.248
|
|
|
|
heart looping
|
GO:0001947 |
94 |
0.247
|
|
|
|
pectoral fin development
|
GO:0033339 |
50 |
0.244
|
|
|
|
chordate embryonic development
|
GO:0043009 |
271 |
0.234
|
|
|
|
embryonic skeletal system morphogenesis
|
GO:0048704 |
93 |
0.229
|
|
|
|
regulation of primary metabolic process
|
GO:0080090 |
311 |
0.225
|
|
|
|
heterocycle biosynthetic process
|
GO:0018130 |
215 |
0.224
|
|
|
|
transcription dna templated
|
GO:0006351 |
181 |
0.218
|
|
|
|
cellular aromatic compound metabolic process
|
GO:0006725 |
295 |
0.212
|
|
|
|
embryonic heart tube morphogenesis
|
GO:0003143 |
108 |
0.211
|
|
|
|
cell adhesion
|
GO:0007155 |
40 |
0.207
|
|
|
|
cellular macromolecule biosynthetic process
|
GO:0034645 |
224 |
0.203
|
|
|
|
regulation of developmental process
|
GO:0050793 |
247 |
0.198
|
|
|
|
single organism organelle organization
|
GO:1902589 |
199 |
0.197
|
|
|
|
regulation of multicellular organismal development
|
GO:2000026 |
223 |
0.193
|
|
|
|
transcription from rna polymerase ii promoter
|
GO:0006366 |
80 |
0.190
|
|
|
|
otic vesicle morphogenesis
|
GO:0071600 |
34 |
0.190
|
|
|
|
regulation of biosynthetic process
|
GO:0009889 |
250 |
0.189
|
|
|
|
nitrogen compound metabolic process
|
GO:0006807 |
319 |
0.188
|
|
|
|
regulation of metabolic process
|
GO:0019222 |
359 |
0.187
|
|
|
|
organic cyclic compound metabolic process
|
GO:1901360 |
301 |
0.185
|
|
|
|
aromatic compound biosynthetic process
|
GO:0019438 |
217 |
0.177
|
|
|
|
heart morphogenesis
|
GO:0003007 |
156 |
0.175
|
|
|
|
nucleobase containing compound metabolic process
|
GO:0006139 |
274 |
0.174
|
|
|
|
regulation of nucleobase containing compound metabolic process
|
GO:0019219 |
250 |
0.173
|
|
|
|
regulation of cellular biosynthetic process
|
GO:0031326 |
245 |
0.169
|
|
|
|
cell matrix adhesion
|
GO:0007160 |
4 |
0.168
|
|
|
|
determination of heart left right asymmetry
|
GO:0061371 |
117 |
0.165
|
|
|
|
immune system process
|
GO:0002376 |
241 |
0.162
|
|
|
|
embryonic heart tube development
|
GO:0035050 |
133 |
0.160
|
|
|
|
negative regulation of cellular biosynthetic process
|
GO:0031327 |
55 |
0.158
|
|
|
|
inner ear development
|
GO:0048839 |
126 |
0.156
|
|
|
|
aging
|
GO:0007568 |
2 |
0.154
|
|
|
|
negative regulation of cellular macromolecule biosynthetic process
|
GO:2000113 |
48 |
0.152
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
86 |
0.150
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
4 |
0.149
|
|
|
|
neuron differentiation
|
GO:0030182 |
353 |
0.148
|
|
|
|
negative regulation of biosynthetic process
|
GO:0009890 |
55 |
0.147
|
|
|
|
muscle organ development
|
GO:0007517 |
101 |
0.143
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
110 |
0.142
|
|
|
|
skeletal system development
|
GO:0001501 |
181 |
0.142
|
|
|
|
epithelial cell differentiation
|
GO:0030855 |
116 |
0.140
|
|
|
|
muscle tissue development
|
GO:0060537 |
110 |
0.140
|
|
|
|
morphogenesis of an epithelium
|
GO:0002009 |
333 |
0.140
|
|
|
|
central nervous system development
|
GO:0007417 |
387 |
0.137
|
|
|
|
negative regulation of transcription dna templated
|
GO:0045892 |
45 |
0.132
|
|
|
|
generation of neurons
|
GO:0048699 |
385 |
0.129
|
|
|
|
erythrocyte homeostasis
|
GO:0034101 |
55 |
0.129
|
|
|
|
cellular nitrogen compound biosynthetic process
|
GO:0044271 |
218 |
0.129
|
|
|
|
developmental pigmentation
|
GO:0048066 |
48 |
0.125
|
|
|
|
regulation of cell differentiation
|
GO:0045595 |
142 |
0.120
|
|
|
|
hematopoietic or lymphoid organ development
|
GO:0048534 |
191 |
0.119
|
|
|
|
biosynthetic process
|
GO:0009058 |
294 |
0.117
|
|
|
|
negative regulation of cellular metabolic process
|
GO:0031324 |
77 |
0.117
|
|
|
|
actin filament based process
|
GO:0030029 |
64 |
0.115
|
|
|
|
regulation of gene expression
|
GO:0010468 |
265 |
0.114
|
|
|
|
cellular nitrogen compound metabolic process
|
GO:0034641 |
290 |
0.113
|
|
|
|
erythrocyte differentiation
|
GO:0030218 |
54 |
0.109
|
|
|
|
negative regulation of biological process
|
GO:0048519 |
304 |
0.108
|
|
|
|
negative regulation of nucleobase containing compound metabolic process
|
GO:0045934 |
59 |
0.107
|
|
|
|
tube morphogenesis
|
GO:0035239 |
349 |
0.106
|
|
|
|
nucleic acid metabolic process
|
GO:0090304 |
244 |
0.105
|
|
|
|
regulation of cell matrix adhesion
|
GO:0001952 |
1 |
0.105
|
|
|
|
somitogenesis
|
GO:0001756 |
87 |
0.104
|
|
|
|
regulation of cell substrate adhesion
|
GO:0010810 |
1 |
0.104
|
|
|
|
response to stress
|
GO:0006950 |
263 |
0.103
|
|
|
|
negative regulation of rna metabolic process
|
GO:0051253 |
48 |
0.102
|
|
|
|
pectoral fin morphogenesis
|
GO:0035138 |
29 |
0.102
|
|
|
|
negative regulation of cellular process
|
GO:0048523 |
283 |
0.099
|
|
|
|
cell morphogenesis
|
GO:0000902 |
289 |
0.099
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
102 |
0.098
|
|
|
|
negative regulation of nitrogen compound metabolic process
|
GO:0051172 |
59 |
0.096
|
|
|
|
regulation of organ growth
|
GO:0046620 |
3 |
0.096
|
|
|
|
appendage morphogenesis
|
GO:0035107 |
56 |
0.095
|
|
|
|
kidney development
|
GO:0001822 |
92 |
0.093
|
|
|
|
endocrine system development
|
GO:0035270 |
65 |
0.093
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
25 |
0.093
|
|
|
|
mesenchymal cell differentiation
|
GO:0048762 |
87 |
0.092
|
|
|
|
embryonic skeletal system development
|
GO:0048706 |
97 |
0.092
|
|
|
|
myeloid cell development
|
GO:0061515 |
32 |
0.091
|
|
|
|
mesoderm development
|
GO:0007498 |
88 |
0.091
|
|
|
|
regulation of multicellular organismal process
|
GO:0051239 |
277 |
0.088
|
|
|
|
positive regulation of metabolic process
|
GO:0009893 |
108 |
0.088
|
|
|
|
mesenchyme development
|
GO:0060485 |
127 |
0.086
|
|
|
|
positive regulation of transport
|
GO:0051050 |
2 |
0.083
|
|
|
|
regulation of heart growth
|
GO:0060420 |
2 |
0.082
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
29 |
0.082
|
|
|
|
pigment cell differentiation
|
GO:0050931 |
38 |
0.082
|
|
|
|
camera type eye morphogenesis
|
GO:0048593 |
108 |
0.081
|
|
|
|
muscle structure development
|
GO:0061061 |
196 |
0.081
|
|
|
|
gene expression
|
GO:0010467 |
252 |
0.081
|
|
|
|
larval development
|
GO:0002164 |
2 |
0.079
|
|
|
|
renal system development
|
GO:0072001 |
94 |
0.078
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
51 |
0.077
|
|
|
|
heart process
|
GO:0003015 |
71 |
0.075
|
|
|
|
somite development
|
GO:0061053 |
96 |
0.073
|
|
|
|
negative regulation of rna biosynthetic process
|
GO:1902679 |
45 |
0.073
|
|
|
|
positive regulation of biological process
|
GO:0048518 |
253 |
0.072
|
|
|
|
positive regulation of nucleobase containing compound metabolic process
|
GO:0045935 |
69 |
0.072
|
|
|
|
fin morphogenesis
|
GO:0033334 |
53 |
0.071
|
|
|
|
appendage development
|
GO:0048736 |
80 |
0.071
|
|
|
|
neural crest cell development
|
GO:0014032 |
62 |
0.070
|
|
|
|
negative regulation of macromolecule metabolic process
|
GO:0010605 |
76 |
0.069
|
|
|
|
embryonic appendage morphogenesis
|
GO:0035113 |
30 |
0.067
|
|
|
|
digestive tract development
|
GO:0048565 |
265 |
0.067
|
|
|
|
cellular component movement
|
GO:0006928 |
335 |
0.067
|
|
|
|
response to drug
|
GO:0042493 |
3 |
0.067
|
|
|
|
neuroepithelial cell differentiation
|
GO:0060563 |
26 |
0.066
|
|
|
|
embryo development ending in birth or egg hatching
|
GO:0009792 |
271 |
0.066
|
|
|
|
multicellular organism growth
|
GO:0035264 |
4 |
0.065
|
|
|
|
pigmentation
|
GO:0043473 |
85 |
0.065
|
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
3 |
0.064
|
|
|
|
regulation of response to stimulus
|
GO:0048583 |
269 |
0.064
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
3 |
0.064
|
|
|
|
protein targeting to nucleus
|
GO:0044744 |
3 |
0.064
|
|
|
|
transport
|
GO:0006810 |
220 |
0.063
|
|
|
|
neuron projection development
|
GO:0031175 |
180 |
0.062
|
|
|
|
embryonic viscerocranium morphogenesis
|
GO:0048703 |
52 |
0.062
|
|
|
|
regulation of programmed cell death
|
GO:0043067 |
101 |
0.061
|
|
|
|
cellular biosynthetic process
|
GO:0044249 |
286 |
0.061
|
|
|
|
negative regulation of cytokine production
|
GO:0001818 |
1 |
0.060
|
|
|
|
negative regulation of nucleic acid templated transcription
|
GO:1903507 |
45 |
0.059
|
|
|
|
glial cell development
|
GO:0021782 |
20 |
0.059
|
|
|
|
positive regulation of macromolecule metabolic process
|
GO:0010604 |
93 |
0.058
|
|
|
|
sympathetic nervous system development
|
GO:0048485 |
3 |
0.058
|
|
|
|
embryonic cranial skeleton morphogenesis
|
GO:0048701 |
90 |
0.058
|
|
|
|
heterophilic cell cell adhesion via plasma membrane cell adhesion molecules
|
GO:0007157 |
2 |
0.058
|
|
|
|
cell migration
|
GO:0016477 |
237 |
0.058
|
|
|
|
cell proliferation
|
GO:0008283 |
80 |
0.057
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
4 |
0.056
|
|
|
|
organelle organization
|
GO:0006996 |
227 |
0.055
|
|
|
|
cardiac atrium morphogenesis
|
GO:0003209 |
2 |
0.054
|
|
|
|
olfactory bulb development
|
GO:0021772 |
4 |
0.054
|
|
|
|
nephron morphogenesis
|
GO:0072028 |
2 |
0.054
|
|
|
|
enzyme linked receptor protein signaling pathway
|
GO:0007167 |
106 |
0.054
|
|
|
|
regulation of nitrogen compound metabolic process
|
GO:0051171 |
251 |
0.053
|
|
|
|
positive regulation of cellular process
|
GO:0048522 |
201 |
0.052
|
|
|
|
b cell activation
|
GO:0042113 |
2 |
0.051
|
|
|
|
regulation of apoptotic process
|
GO:0042981 |
98 |
0.050
|
|
|
|
cellular protein metabolic process
|
GO:0044267 |
129 |
0.050
|
|
|
|
regionalization
|
GO:0003002 |
274 |
0.049
|
|
|
|
nephron epithelium morphogenesis
|
GO:0072088 |
1 |
0.049
|
|
|
|
ear development
|
GO:0043583 |
127 |
0.049
|
|
|
|
response to nicotine
|
GO:0035094 |
2 |
0.047
|
|
|
|
single organism localization
|
GO:1902578 |
225 |
0.047
|
|
|
|
negative regulation of cell differentiation
|
GO:0045596 |
46 |
0.047
|
|
|
|
otic vesicle development
|
GO:0071599 |
42 |
0.046
|
|
|
|
cellular component assembly
|
GO:0022607 |
170 |
0.046
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
19 |
0.046
|
|
|
|
skeletal muscle tissue development
|
GO:0007519 |
67 |
0.046
|
|
|
|
regulation of nervous system development
|
GO:0051960 |
90 |
0.045
|
|
|
|
aorta development
|
GO:0035904 |
4 |
0.045
|
|
|
|
development of primary female sexual characteristics
|
GO:0046545 |
4 |
0.045
|
|
|
|
establishment of localization
|
GO:0051234 |
244 |
0.044
|
|
|
|
protein localization to nucleus
|
GO:0034504 |
3 |
0.043
|
|
|
|
cell motility
|
GO:0048870 |
244 |
0.043
|
|
|
|
protein metabolic process
|
GO:0019538 |
183 |
0.043
|
|
|
|
death
|
GO:0016265 |
121 |
0.042
|
|
|
|
stem cell differentiation
|
GO:0048863 |
117 |
0.042
|
|
|
|
system process
|
GO:0003008 |
185 |
0.042
|
|
|
|
skeletal muscle fiber development
|
GO:0048741 |
35 |
0.042
|
|
|
|
somatic muscle development
|
GO:0007525 |
4 |
0.042
|
|
|
|
embryonic retina morphogenesis in camera type eye
|
GO:0060059 |
22 |
0.041
|
|
|
|
response to organic substance
|
GO:0010033 |
153 |
0.041
|
|
|
|
cardiac atrium development
|
GO:0003230 |
4 |
0.041
|
|
|
|
developmental growth
|
GO:0048589 |
166 |
0.040
|
|
|
|
regulation of myeloid cell differentiation
|
GO:0045637 |
8 |
0.040
|
|
|
|
positive regulation of muscle organ development
|
GO:0048636 |
1 |
0.040
|
|
|
|
regulation of transcription from rna polymerase ii promoter
|
GO:0006357 |
114 |
0.039
|
|
|
|
striated muscle cell differentiation
|
GO:0051146 |
129 |
0.039
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
7 |
0.038
|
|
|
|
positive regulation of muscle tissue development
|
GO:1901863 |
1 |
0.038
|
|
|
|
renal tubule morphogenesis
|
GO:0061333 |
1 |
0.038
|
|
|
|
endothelial cell fate commitment
|
GO:0060839 |
3 |
0.038
|
|
|
|
glial cell differentiation
|
GO:0010001 |
42 |
0.038
|
|
|
|
anterior posterior pattern specification
|
GO:0009952 |
152 |
0.037
|
|
|
|
sensory system development
|
GO:0048880 |
76 |
0.037
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
56 |
0.037
|
|
|
|
photoreceptor cell differentiation
|
GO:0046530 |
55 |
0.037
|
|
|
|
urogenital system development
|
GO:0001655 |
97 |
0.037
|
|
|
|
meiotic nuclear division
|
GO:0007126 |
4 |
0.036
|
|
|
|
negative regulation of macromolecule biosynthetic process
|
GO:0010558 |
48 |
0.036
|
|
|
|
cellular component biogenesis
|
GO:0044085 |
178 |
0.036
|
|
|
|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
107 |
0.036
|
|
|
|
ear morphogenesis
|
GO:0042471 |
64 |
0.036
|
|
|
|
specification of axis polarity
|
GO:0065001 |
4 |
0.036
|
|
|
|
single organism nuclear import
|
GO:1902593 |
3 |
0.035
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
216 |
0.035
|
|
|
|
organic substance transport
|
GO:0071702 |
58 |
0.035
|
|
|
|
regulation of reproductive process
|
GO:2000241 |
4 |
0.034
|
|
|
|
regulation of cell death
|
GO:0010941 |
103 |
0.034
|
|
|
|
tissue remodeling
|
GO:0048771 |
4 |
0.034
|
|
|
|
regulation of cell shape
|
GO:0008360 |
1 |
0.034
|
|
|
|
exocrine pancreas development
|
GO:0031017 |
28 |
0.034
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
23 |
0.034
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
1 |
0.034
|
|
|
|
homeostatic process
|
GO:0042592 |
142 |
0.034
|
|
|
|
heart valve formation
|
GO:0003188 |
4 |
0.034
|
|
|
|
macromolecular complex subunit organization
|
GO:0043933 |
74 |
0.034
|
|
|
|
cell cycle g1 s phase transition
|
GO:0044843 |
1 |
0.034
|
|
|
|
blood vessel development
|
GO:0001568 |
246 |
0.033
|
|
|
|
regulation of cellular component organization
|
GO:0051128 |
86 |
0.033
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
3 |
0.033
|
|
|
|
pancreas development
|
GO:0031016 |
84 |
0.033
|
|
|
|
regulation of cell communication
|
GO:0010646 |
232 |
0.033
|
|
|
|
nephron tubule morphogenesis
|
GO:0072078 |
1 |
0.033
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
231 |
0.032
|
|
|
|
lipid storage
|
GO:0019915 |
1 |
0.032
|
|
|
|
positive regulation of nitrogen compound metabolic process
|
GO:0051173 |
69 |
0.032
|
|
|
|
negative regulation of multicellular organismal process
|
GO:0051241 |
69 |
0.032
|
|
|
|
cell death
|
GO:0008219 |
121 |
0.032
|
|
|
|
erk1 and erk2 cascade
|
GO:0070371 |
4 |
0.032
|
|
|
|
sodium ion transport
|
GO:0006814 |
24 |
0.031
|
|
|
|
regulation of blood pressure
|
GO:0008217 |
1 |
0.031
|
|
|
|
positive regulation of protein metabolic process
|
GO:0051247 |
23 |
0.030
|
|
|
|
cardiac muscle cell differentiation
|
GO:0055007 |
30 |
0.030
|
|
|
|
cell cycle
|
GO:0007049 |
93 |
0.030
|
|
|
|
renal system process
|
GO:0003014 |
14 |
0.030
|
|
|
|
regulation of intracellular protein transport
|
GO:0033157 |
3 |
0.030
|
|
|
|
maintenance of location
|
GO:0051235 |
4 |
0.030
|
|
|
|
negative regulation of myeloid cell differentiation
|
GO:0045638 |
1 |
0.030
|
|
|
|
ectodermal placode morphogenesis
|
GO:0071697 |
32 |
0.030
|
|
|
|
regulation of protein transport
|
GO:0051223 |
3 |
0.029
|
|
|
|
atrioventricular valve development
|
GO:0003171 |
11 |
0.029
|
|
|
|
cell morphogenesis involved in neuron differentiation
|
GO:0048667 |
163 |
0.029
|
|
|
|
compound eye development
|
GO:0048749 |
2 |
0.029
|
|
|
|
regulation of immune system process
|
GO:0002682 |
34 |
0.029
|
|
|
|
cerebellar granular layer development
|
GO:0021681 |
3 |
0.029
|
|
|
|
organonitrogen compound metabolic process
|
GO:1901564 |
74 |
0.029
|
|
|
|
axis elongation involved in somitogenesis
|
GO:0090245 |
2 |
0.029
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
2 |
0.029
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
48 |
0.028
|
|
|
|
microtubule organizing center organization
|
GO:0031023 |
1 |
0.028
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
22 |
0.028
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
11 |
0.028
|
|
|
|
mesenchymal cell development
|
GO:0014031 |
78 |
0.028
|
|
|
|
respiratory system development
|
GO:0060541 |
5 |
0.028
|
|
|
|
positive regulation of cellular metabolic process
|
GO:0031325 |
94 |
0.028
|
|
|
|
skin development
|
GO:0043588 |
54 |
0.028
|
|
|
|
programmed cell death
|
GO:0012501 |
119 |
0.028
|
|
|
|
regulation of multicellular organism growth
|
GO:0040014 |
4 |
0.028
|
|
|
|
adherens junction organization
|
GO:0034332 |
4 |
0.028
|
|
|
|
positive regulation of transcription dna templated
|
GO:0045893 |
57 |
0.028
|
|
|
|
carbohydrate biosynthetic process
|
GO:0016051 |
1 |
0.028
|
|
|
|
muscle fiber development
|
GO:0048747 |
52 |
0.028
|
|
|
|
eye photoreceptor cell differentiation
|
GO:0001754 |
45 |
0.028
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
5 |
0.027
|
|
|
|
cellular response to starvation
|
GO:0009267 |
1 |
0.027
|
|
|
|
regulation of vasculature development
|
GO:1901342 |
33 |
0.027
|
|
|
|
biological adhesion
|
GO:0022610 |
40 |
0.027
|
|
|
|
developmental programmed cell death
|
GO:0010623 |
4 |
0.027
|
|
|
|
response to chemical
|
GO:0042221 |
320 |
0.027
|
|
|
|
establishment of protein localization to organelle
|
GO:0072594 |
4 |
0.027
|
|
|
|
phagocytosis
|
GO:0006909 |
3 |
0.027
|
|
|
|
lateral line system development
|
GO:0048925 |
76 |
0.027
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
35 |
0.026
|
|
|
|
regulation of anatomical structure morphogenesis
|
GO:0022603 |
130 |
0.026
|
|
|
|
sex determination
|
GO:0007530 |
1 |
0.026
|
|
|
|
regulation of gtpase activity
|
GO:0043087 |
2 |
0.026
|
|
|
|
phosphorus metabolic process
|
GO:0006793 |
109 |
0.026
|
|
|
|
action potential
|
GO:0001508 |
19 |
0.026
|
|
|
|
osteoclast differentiation
|
GO:0030316 |
1 |
0.026
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
2 |
0.026
|
|
|
|
response to wounding
|
GO:0009611 |
116 |
0.026
|
|
|
|
neuronal action potential
|
GO:0019228 |
18 |
0.026
|
|
|
|
cellular response to organic substance
|
GO:0071310 |
105 |
0.025
|
|
|
|
regulation of stem cell differentiation
|
GO:2000736 |
4 |
0.025
|
|
|
|
myelination
|
GO:0042552 |
18 |
0.025
|
|
|
|
negative regulation of transcription from rna polymerase ii promoter
|
GO:0000122 |
16 |
0.025
|
|
|
|
inner ear morphogenesis
|
GO:0042472 |
63 |
0.025
|
|
|
|
stem cell development
|
GO:0048864 |
82 |
0.025
|
|
|
|
regulation of molecular function
|
GO:0065009 |
70 |
0.025
|
|
|
|
cell fate specification
|
GO:0001708 |
68 |
0.025
|
|
|
|
organelle assembly
|
GO:0070925 |
110 |
0.025
|
|
|
|
epidermis development
|
GO:0008544 |
48 |
0.025
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
23 |
0.025
|
|
|
|
cellular response to chemical stimulus
|
GO:0070887 |
157 |
0.025
|
|
|
|
head development
|
GO:0060322 |
303 |
0.025
|
|
|
|
positive regulation of muscle cell differentiation
|
GO:0051149 |
1 |
0.025
|
|
|
|
cell growth
|
GO:0016049 |
57 |
0.024
|
|
|
|
epidermal cell differentiation
|
GO:0009913 |
36 |
0.024
|
|
|
|
regulation of cell development
|
GO:0060284 |
100 |
0.024
|
|
|
|
endoderm development
|
GO:0007492 |
49 |
0.024
|
|
|
|
macromolecule modification
|
GO:0043412 |
111 |
0.024
|
|
|
|
b cell differentiation
|
GO:0030183 |
1 |
0.024
|
|
|
|
stem cell maintenance
|
GO:0019827 |
4 |
0.024
|
|
|
|
photoreceptor cell fate specification
|
GO:0043704 |
1 |
0.023
|
|
|
|
apoptotic process
|
GO:0006915 |
116 |
0.023
|
|
|
|
mesoderm morphogenesis
|
GO:0048332 |
51 |
0.023
|
|
|
|
hindbrain development
|
GO:0030902 |
91 |
0.023
|
|
|
|
sulfur compound transport
|
GO:0072348 |
3 |
0.023
|
|
|
|
regulation of cardiac muscle tissue development
|
GO:0055024 |
1 |
0.023
|
|
|
|
protein localization to plasma membrane
|
GO:0072659 |
1 |
0.023
|
|
|
|
positive regulation of cell fate commitment
|
GO:0010455 |
1 |
0.023
|
|
|
|
regulation of cell proliferation
|
GO:0042127 |
37 |
0.023
|
|
|
|
positive regulation of macromolecule biosynthetic process
|
GO:0010557 |
59 |
0.023
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
16 |
0.022
|
|
|
|
glomerulus development
|
GO:0032835 |
27 |
0.022
|
|
|
|
regulation of peptidyl tyrosine phosphorylation
|
GO:0050730 |
1 |
0.022
|
|
|
|
response to hexose
|
GO:0009746 |
3 |
0.022
|
|
|
|
otic vesicle formation
|
GO:0030916 |
27 |
0.022
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
2 |
0.022
|
|
|
|
notochord development
|
GO:0030903 |
54 |
0.022
|
|
|
|
midbrain hindbrain boundary development
|
GO:0030917 |
23 |
0.022
|
|
|
|
rhombomere 5 development
|
GO:0021571 |
4 |
0.022
|
|
|
|
embryonic pectoral fin morphogenesis
|
GO:0035118 |
24 |
0.022
|
|
|
|
single organism cellular localization
|
GO:1902580 |
46 |
0.022
|
|
|
|
gtp metabolic process
|
GO:0046039 |
4 |
0.021
|
|
|
|
heart valve development
|
GO:0003170 |
14 |
0.021
|
|
|
|
nephron tubule epithelial cell differentiation
|
GO:0072160 |
1 |
0.021
|
|
|
|
paraxial mesoderm development
|
GO:0048339 |
8 |
0.021
|
|
|
|
cellular response to drug
|
GO:0035690 |
1 |
0.021
|
|
|
|
positive regulation of rna metabolic process
|
GO:0051254 |
59 |
0.021
|
|
|
|
apoptotic process involved in morphogenesis
|
GO:0060561 |
2 |
0.021
|
|
|
|
proteolysis
|
GO:0006508 |
38 |
0.021
|
|
|
|
cartilage condensation
|
GO:0001502 |
3 |
0.021
|
|
|
|
cell projection organization
|
GO:0030030 |
284 |
0.021
|
|
|
|
positive regulation of striated muscle cell differentiation
|
GO:0051155 |
1 |
0.021
|
|
|
|
angiogenesis
|
GO:0001525 |
158 |
0.021
|
|
|
|
organic acid metabolic process
|
GO:0006082 |
31 |
0.021
|
|
|
|
positive regulation of transcription from rna polymerase ii promoter
|
GO:0045944 |
22 |
0.021
|
|
|
|
chromatin organization
|
GO:0006325 |
22 |
0.021
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
1 |
0.021
|
|
|
|
regulation of cell proliferation involved in heart morphogenesis
|
GO:2000136 |
2 |
0.021
|
|
|
|
regulation of cell activation
|
GO:0050865 |
1 |
0.020
|
|
|
|
cell part morphogenesis
|
GO:0032990 |
246 |
0.020
|
|
|
|
nephron development
|
GO:0072006 |
31 |
0.020
|
|
|
|
chromosome organization
|
GO:0051276 |
31 |
0.020
|
|
|
|
regulation of hormone secretion
|
GO:0046883 |
2 |
0.020
|
|
|
|
localization of cell
|
GO:0051674 |
244 |
0.020
|
|
|
|
cytoskeleton organization
|
GO:0007010 |
96 |
0.020
|
|
|
|
cytosolic calcium ion transport
|
GO:0060401 |
3 |
0.020
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
15 |
0.020
|
|
|
|
brain development
|
GO:0007420 |
293 |
0.020
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
62 |
0.020
|
|
|
|
astrocyte differentiation
|
GO:0048708 |
1 |
0.020
|
|
|
|
g1 s transition of mitotic cell cycle
|
GO:0000082 |
1 |
0.019
|
|
|
|
response to monosaccharide
|
GO:0034284 |
3 |
0.019
|
|
|
|
cell fate commitment
|
GO:0045165 |
99 |
0.019
|
|
|
|
regulation of system process
|
GO:0044057 |
40 |
0.019
|
|
|
|
negative regulation of programmed cell death
|
GO:0043069 |
58 |
0.019
|
|
|
|
single organism metabolic process
|
GO:0044710 |
217 |
0.019
|
|
|
|
water homeostasis
|
GO:0030104 |
4 |
0.019
|
|
|
|
small molecule metabolic process
|
GO:0044281 |
77 |
0.019
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
2 |
0.019
|
|
|
|
regulation of hematopoietic progenitor cell differentiation
|
GO:1901532 |
1 |
0.019
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
139 |
0.019
|
|
|
|
peptide transport
|
GO:0015833 |
1 |
0.019
|
|
|
|
positive regulation of histone modification
|
GO:0031058 |
1 |
0.019
|
|
|
|
glucose homeostasis
|
GO:0042593 |
1 |
0.019
|
|
|
|
macromolecule deacylation
|
GO:0098732 |
3 |
0.019
|
|
|
|
regulation of muscle contraction
|
GO:0006937 |
3 |
0.019
|
|
|
|
cilium morphogenesis
|
GO:0060271 |
85 |
0.019
|
|
|
|
negative regulation of cell fate specification
|
GO:0009996 |
11 |
0.019
|
|
|
|
immunoglobulin production
|
GO:0002377 |
1 |
0.019
|
|
|
|
digestive system development
|
GO:0055123 |
289 |
0.019
|
|
|
|
negative regulation of secretion
|
GO:0051048 |
2 |
0.018
|
|
|
|
stem cell fate commitment
|
GO:0048865 |
1 |
0.018
|
|
|
|
enteric nervous system development
|
GO:0048484 |
12 |
0.018
|
|
|
|
gtp catabolic process
|
GO:0006184 |
2 |
0.018
|
|
|
|
renal system vasculature development
|
GO:0061437 |
2 |
0.018
|
|
|
|
epithelial cell fate commitment
|
GO:0072148 |
11 |
0.018
|
|
|
|
smooth muscle contraction
|
GO:0006939 |
2 |
0.018
|
|
|
|
cellular response to external stimulus
|
GO:0071496 |
2 |
0.018
|
|
|
|
aorta morphogenesis
|
GO:0035909 |
3 |
0.018
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
29 |
0.018
|
|
|
|
apoptotic process involved in development
|
GO:1902742 |
2 |
0.018
|
|
|
|
circulatory system process
|
GO:0003013 |
87 |
0.018
|
|
|
|
pronephros development
|
GO:0048793 |
69 |
0.018
|
|
|
|
nephron epithelium development
|
GO:0072009 |
16 |
0.018
|
|
|
|
growth
|
GO:0040007 |
174 |
0.018
|
|
|
|
positive regulation of developmental process
|
GO:0051094 |
50 |
0.018
|
|
|
|
production of molecular mediator of immune response
|
GO:0002440 |
2 |
0.018
|
|
|
|
cerebellar granular layer formation
|
GO:0021684 |
3 |
0.017
|
|
|
|
positive regulation of epithelial cell proliferation
|
GO:0050679 |
1 |
0.017
|
|
|
|
response to endogenous stimulus
|
GO:0009719 |
83 |
0.017
|
|
|
|
negative regulation of developmental process
|
GO:0051093 |
65 |
0.017
|
|
|
|
somatic stem cell maintenance
|
GO:0035019 |
1 |
0.017
|
|
|
|
negative regulation of kinase activity
|
GO:0033673 |
4 |
0.017
|
|
|
|
gland development
|
GO:0048732 |
143 |
0.017
|
|
|
|
type b pancreatic cell development
|
GO:0003323 |
4 |
0.017
|
|
|
|
endocardium morphogenesis
|
GO:0003160 |
4 |
0.017
|
|
|
|
inositol lipid mediated signaling
|
GO:0048017 |
2 |
0.017
|
|
|
|
regulation of gtp catabolic process
|
GO:0033124 |
2 |
0.017
|
|
|
|
regulation of production of molecular mediator of immune response
|
GO:0002700 |
1 |
0.017
|
|
|
|
negative regulation of gliogenesis
|
GO:0014014 |
1 |
0.017
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
1 |
0.017
|
|
|
|
gastrulation with mouth forming second
|
GO:0001702 |
44 |
0.017
|
|
|
|
cellular protein modification process
|
GO:0006464 |
100 |
0.017
|
|
|
|
negative regulation of apoptotic process
|
GO:0043066 |
55 |
0.017
|
|
|
|
kidney morphogenesis
|
GO:0060993 |
15 |
0.017
|
|
|
|
viral process
|
GO:0016032 |
1 |
0.017
|
|
|
|
regulation of protein metabolic process
|
GO:0051246 |
56 |
0.017
|
|
|
|
protein stabilization
|
GO:0050821 |
2 |
0.017
|
|
|
|
nuclear import
|
GO:0051170 |
3 |
0.017
|
|
|
|
rostrocaudal neural tube patterning
|
GO:0021903 |
29 |
0.017
|
|
|
|
signal transduction
|
GO:0007165 |
455 |
0.017
|
|
|
|
endocrine pancreas development
|
GO:0031018 |
27 |
0.017
|
|
|
|
endocardium formation
|
GO:0060214 |
1 |
0.016
|
|
|
|
heart growth
|
GO:0060419 |
7 |
0.016
|
|
|
|
lens development in camera type eye
|
GO:0002088 |
22 |
0.016
|
|
|
|
definitive hemopoiesis
|
GO:0060216 |
18 |
0.016
|
|
|
|
kidney epithelium development
|
GO:0072073 |
23 |
0.016
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
56 |
0.016
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
53 |
0.016
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
4 |
0.016
|
|
|
|
cranial ganglion development
|
GO:0061550 |
3 |
0.016
|
|
|
|
stem cell division
|
GO:0017145 |
1 |
0.016
|
|
|
|
blood circulation
|
GO:0008015 |
87 |
0.016
|
|
|
|
regulation of binding
|
GO:0051098 |
3 |
0.016
|
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
4 |
0.016
|
|
|
|
segmentation
|
GO:0035282 |
97 |
0.016
|
|
|
|
outflow tract morphogenesis
|
GO:0003151 |
1 |
0.016
|
|
|
|
centrosome cycle
|
GO:0007098 |
1 |
0.016
|
|
|
|
connective tissue development
|
GO:0061448 |
99 |
0.016
|
|
|
|
regulation of mesenchymal cell proliferation
|
GO:0010464 |
1 |
0.016
|
|
|
|
epidermal cell fate specification
|
GO:0009957 |
4 |
0.016
|
|
|
|
melanocyte differentiation
|
GO:0030318 |
26 |
0.016
|
|
|
|
cell aggregation
|
GO:0098743 |
3 |
0.016
|
|
|
|
multi organism process
|
GO:0051704 |
134 |
0.016
|
|
|
|
histone h3 k4 methylation
|
GO:0051568 |
2 |
0.015
|
|
|
|
oocyte maturation
|
GO:0001556 |
4 |
0.015
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
27 |
0.015
|
|
|
|
multicellular organismal response to stress
|
GO:0033555 |
2 |
0.015
|
|
|
|
single organism reproductive process
|
GO:0044702 |
40 |
0.015
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
42 |
0.015
|
|
|
|
meiotic cell cycle process
|
GO:1903046 |
3 |
0.015
|
|
|
|
neural tube development
|
GO:0021915 |
62 |
0.015
|
|
|
|
single organism biosynthetic process
|
GO:0044711 |
71 |
0.015
|
|
|
|
axon ensheathment in central nervous system
|
GO:0032291 |
2 |
0.015
|
|
|
|
pancreatic a cell development
|
GO:0003322 |
2 |
0.015
|
|
|
|
i kappab kinase nf kappab signaling
|
GO:0007249 |
4 |
0.015
|
|
|
|
heart contraction
|
GO:0060047 |
71 |
0.015
|
|
|
|
stem cell proliferation
|
GO:0072089 |
4 |
0.015
|
|
|
|
amine metabolic process
|
GO:0009308 |
2 |
0.015
|
|
|
|
negative regulation of protein kinase activity
|
GO:0006469 |
4 |
0.015
|
|
|
|
cartilage development
|
GO:0051216 |
96 |
0.015
|
|
|
|
embryonic eye morphogenesis
|
GO:0048048 |
30 |
0.015
|
|
|
|
positive regulation of striated muscle tissue development
|
GO:0045844 |
1 |
0.015
|
|
|
|
regulation of localization
|
GO:0032879 |
104 |
0.014
|
|
|
|
axon ensheathment
|
GO:0008366 |
18 |
0.014
|
|
|
|
female gonad development
|
GO:0008585 |
4 |
0.014
|
|
|
|
regulation of signal transduction
|
GO:0009966 |
225 |
0.014
|
|
|
|
negative regulation of sequence specific dna binding transcription factor activity
|
GO:0043433 |
2 |
0.014
|
|
|
|
mesenchymal cell proliferation
|
GO:0010463 |
1 |
0.014
|
|
|
|
cell morphogenesis involved in differentiation
|
GO:0000904 |
195 |
0.014
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
2 |
0.014
|
|
|
|
negative regulation of cell death
|
GO:0060548 |
60 |
0.014
|
|
|
|
glial cell proliferation
|
GO:0014009 |
4 |
0.014
|
|
|
|
regulation of cysteine type endopeptidase activity
|
GO:2000116 |
21 |
0.014
|
|
|
|
regeneration
|
GO:0031099 |
91 |
0.014
|
|
|
|
cardiocyte differentiation
|
GO:0035051 |
44 |
0.014
|
|
|
|
ventricular cardiac muscle tissue development
|
GO:0003229 |
3 |
0.014
|
|
